IDO2 and small cell lung carcinoma: It has been described that SCLC subtypes with low NE marker expression are characterized by increased immune cell infiltration and elevated expression of the immune checkpoints poliovirus receptor and indoleamine 2,3-dioxygenase, which may represent biomarkers and potential therapeutic targets in SCLC [81].